Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

CVS Health : Position Maintained by First National Bank Sioux Falls

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/09/2017 | 04:20pm CET

First National Bank Sioux Falls continued to hold its stake in shares of CVS Health Corp (NYSE:CVS) during the first quarter, according to its most recent disclosure with the SEC. The fund owned 3,230 shares of the pharmacy operators stock at the end of the first quarter. First National Bank Sioux Falls holdings in CVS Health Corp were worth $253,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the company. Factory Mutual Insurance Co. boosted its position in CVS Health Corp by 3.9% in the third quarter. Factory Mutual Insurance Co. now owns 1,343,000 shares of the pharmacy operators stock worth $119,514,000 after buying an additional 50,000 shares during the last quarter. Stack Financial Management Inc boosted its position in CVS Health Corp by 1.9% in the third quarter. Stack Financial Management Inc now owns 274,918 shares of the pharmacy operators stock worth $24,465,000 after buying an additional 5,092 shares during the last quarter. Lee Danner & Bass Inc. boosted its position in CVS Health Corp by 31.3% in the third quarter. Lee Danner & Bass Inc. now owns 46,760 shares of the pharmacy operators stock worth $4,161,000 after buying an additional 11,153 shares during the last quarter. General American Investors Co. Inc. acquired a new position in shares of CVS Health Corp during the third quarter valued at approximately $12,661,000. Finally, K.J. Harrison & Partners Inc boosted its position in shares of CVS Health Corp by 20.5% in the third quarter. K.J. Harrison & Partners Inc now owns 37,620 shares of the pharmacy operators stock valued at $3,348,000 after buying an additional 6,395 shares in the last quarter. Institutional investors and hedge funds own 81.29% of the companys stock.

CVS Health Corp (CVS) traded up 0.35% during midday trading on Thursday, hitting $78.43. 4,096,393 shares of the stock traded hands. The company has a 50-day moving average price of $79.17 and a 200-day moving average price of $79.13. The firm has a market cap of $79.90 billion, a P/E ratio of 16.36 and a beta of 0.85. CVS Health Corp has a 1-year low of $69.30 and a 1-year high of $98.67.

CVS Health Corp (NYSE:CVS) last released its quarterly earnings results on Tuesday, May 2nd. The pharmacy operator reported $1.17 earnings per share (EPS) for the quarter, beating the Zacks consensus estimate of $1.10 by $0.07. CVS Health Corp had a return on equity of 10.97% and a net margin of 2.16%. The business had revenue of $44.51 billion during the quarter, compared to analysts expectations of $44.20 billion. During the same period in the previous year, the business posted $1.18 earnings per share. The firms revenue for the quarter was up 3.0% compared to the same quarter last year. Analysts predict that CVS Health Corp will post $5.87 EPS for the current year.

CVS has been the subject of several recent research reports. Deutsche Bank AG reissued a hold rating and issued a $88.00 price target on shares of CVS Health Corp in a research report on Wednesday, February 8th. Evercore ISI decreased their price objective on shares of CVS Health Corp from $91.50 to $84.00 and set a buy rating for the company in a research report on Thursday, February 9th. Leerink Swann set a $90.00 price objective on shares of CVS Health Corp and gave the stock a buy rating in a research report on Saturday, February 11th. Vetr lowered shares of CVS Health Corp from a buy rating to a hold rating and set a $82.45 price target on the stock. in a research note on Thursday, February 16th. Finally, Bank of America Corp reiterated a buy rating and set a $106.67 price target on shares of CVS Health Corp in a research note on Tuesday, February 28th. Eight investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the companys stock. CVS Health Corp has an average rating of Buy and a consensus price target of $94.45.

In other CVS Health Corp news, EVP Eva C. Boratto sold 6,029 shares of the businesss stock in a transaction dated Friday, March 17th. The stock was sold at an average price of $79.60, for a total transaction of $479,908.40. Following the completion of the sale, the executive vice president now directly owns 41,614 shares of the companys stock, valued at approximately $3,312,474.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Troyen A. Brennan sold 23,849 shares of the companys stock in a transaction dated Tuesday, March 21st. The shares were sold at an average price of $78.73, for a total value of $1,877,631.77. Following the completion of the sale, the executive vice president now directly owns 94,309 shares of the companys stock, valued at $7,424,947.57. The disclosure for this sale can be found here. Insiders sold 139,600 shares of company stock valued at $11,205,962 over the last ninety days. 0.58% of the stock is currently owned by company insiders.

(c) 2017 Al Hilal Publishing and Marketing Group Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH
12/14 CVS HEALTH : chief information officer resigns
12/14 CVS HEALTH : Foundation Announces Grant to Increase Access to Provider Education..
12/14 CVS HEALTH : Solera Health Expands Its Board of Directors with the Addition of H..
12/12 CVS HEALTH : 3 Reasons Why Florida Addiction Recovery Center CEO Is Wary Of $77 ..
12/11 CVS HEALTH : 3 Reasons Why Florida Addiction Recovery Center CEO Is Wary Of $77 ..
12/08 CVS expects U.S. Justice Department to handle review of Aetna deal
12/08 CVS HEALTH : A.M. Best Places Credit Ratings of SilverScript Insurance Company U..
12/08 CVS HEALTH : Greg's Pharmacy, Bluffton, will become a CVS Pharmacy
12/07 MYERS INDUSTRIES : Names Chris DuPaul as Group President, Distribution
12/07 CVS HEALTH : Meningitis B Vaccine Available to Students, Faculty and Staff at UM..
More news
News from SeekingAlpha
12/15 Just Turned 40? How To Reach A Goal Of $1.5 Million.
12/15 MY JOURNEY TO FINANCIAL INDEPENDENCE : 86-Stock November Portfolio Update - Buyi..
12/14 The Next 20 Dividend Achievers Absolutely Trounce The Market
12/14 WALGREENS BOOTS ALLIANCE : Trading At A Bargain
12/13 The Value Of Reliability And Why Omega Healthcare Is A Value Trap
Financials ($)
Sales 2017 184 B
EBIT 2017 9 955 M
Net income 2017 5 255 M
Debt 2017 24 517 M
Yield 2017 2,81%
P/E ratio 2017 14,11
P/E ratio 2018 12,39
EV / Sales 2017 0,52x
EV / Sales 2018 0,49x
Capitalization 71 720 M
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 86,1 $
Spread / Average Target 22%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH-9.24%71 720
WALGREENS BOOTS ALLIANCE-13.34%69 681
EXPRESS SCRIPTS HOLDING CO0.33%39 091
MCKESSON CORPORATION10.51%32 772
AMERISOURCEBERGEN CORP.13.16%19 477
CARDINAL HEALTH INC-15.84%19 023